Linlin Sun.jpg

Linlin Sun

Patent attorney AFD China Intellectual Property Law Office

Contact

email

Published by this author:

Sponsored content

Sponsored by AFD China Intellectual Property Law Office

Supplementary experimental data acceptance criteria in pharmaceutical patent grant and confirmation procedures

Linlin Sun and Xia Zheng of AFD China Intellectual Property Law Office cite two key Chinese Supreme People’s Court cases to clarify the conditions under which supplementary experimental data is accepted

Linlin Sun, April 15 2025